Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Elite Pharmaceuticals Inc. (ELTP) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$31.59M |
|
$18.59M |
|
$18.64M |
|
$12.95M |
|
$22.58M |
|
$9.01M |
|
$11.82M |
|
$20.83M |
|
$20.83M |
|
$18.59M |
|
$18.59M |
|
$18.59M |
|
$18.59M |
|
$9.01M |
|
$9.52M |
|
1.07B |
|
1.14B |
|
$0.02 |
|
$0.01 |
|
| Balance Sheet Financials | |
$96.79M |
|
$10.04M |
|
$29.62M |
|
$126.41M |
|
$13.19M |
|
$3.78M |
|
$32.91M |
|
$46.10M |
|
$80.31M |
|
$74.68M |
|
$80.31M |
|
1.07B |
|
| Cash Flow Statement Financials | |
$14.60M |
|
$-0.53M |
|
$-4.28M |
|
$11.77M |
|
$21.56M |
|
$9.79M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.34 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.04 |
|
0.05 |
|
41.01% |
|
28.53% |
|
28.53% |
|
-- |
|
65.95% |
|
58.86% |
|
$14.07M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
0.74 |
|
0.65 |
|
138.26 |
|
23.15% |
|
24.90% |
|
14.71% |
|
22.11% |
|
$0.07 |
|
$0.01 |
|
$0.01 |
|